Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 심봉석 | - |
dc.date.accessioned | 2016-08-28T11:08:22Z | - |
dc.date.available | 2016-08-28T11:08:22Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.other | OAK-13516 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/229498 | - |
dc.description.abstract | Purpose: Testosterone is essential for the prostate gland's normal growth and development and is also a possible risk factor for prostate cancer. This study's aim was to determine the significance of serum testosterone for prostate-specific antigen (PSA) elevation and prostate cancer prediction in high-risk men. Materials and Methods: The study included 120 patients with PSA > 10 ng/ml who underwent a transrectal-prostate biopsy. Serum testosterone, prostate volume, and PSA density (PSAD) were checked in all patients. Patients were divided into two groups, patients with and those without prostate cancer; and testosterone-related factors, prostate volume, PSA, PSAD, age, prostate cancer prediction rate, and cancer aggressiveness were evaluated. Results: Thirty-five patients (30.2%) were confirmed as having prostate cancer. The average serum testosterone level in patients without and in those with prostate cancer was 452.25±154.62 ng/dl and 458.10±158.84 ng/dl, respectively; average PSA was 17.58±9.02 ng/ml and 18.62±6.53 ng/ml, respectively; and average age was 69.02±7.52 years and 70.69±7.02 years, respectively (p>0.05). Hypogonadal and eugonadal patients showed no significant difference in cancer prevalence (30.3% vs. 32.0%, respectively). The testosterone level did not differ significantly in patients with and those without prostate cancer in either hypogonadal or eugonadal men (p>0.05). Serum testosterone showed no correlation with PSA, PSAD, or age in either group (p>0.05) and was unrelated to prostate cancer risk or aggressiveness (p>0.05). Conclusions: In our study's results, serum testosterone at the time of diagnosis was unrelated to PSA elevation, prostate cancer risk, and aggressiveness. © The Korean Urological Association, 2010. | - |
dc.language | English | - |
dc.title | Significance of serum testosterone for Prostate-Specific Antigen (PSA) elevation and prediction of prostate cancer in patients with PSA above 10 ng/ml | - |
dc.type | Article | - |
dc.relation.issue | 12 | - |
dc.relation.volume | 51 | - |
dc.relation.index | SCOPUS | - |
dc.relation.index | KCI | - |
dc.relation.startpage | 831 | - |
dc.relation.lastpage | 835 | - |
dc.relation.journaltitle | Korean Journal of Urology | - |
dc.identifier.doi | 10.4111/kju.2010.51.12.831 | - |
dc.identifier.scopusid | 2-s2.0-78650877932 | - |
dc.author.google | Koo J.M. | - |
dc.author.google | Shim B.S. | - |
dc.contributor.scopusid | 심봉석(16029359600;57189642773) | - |
dc.date.modifydate | 20230301081001 | - |